000			01769 a2200505 4500
005			20250515114013.0
264		0	_c20080708
008			200807s 0 0 eng d
022			_a0306-4530
024	7		_a10.1016/j.psyneuen.2008.02.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aCoryell, William
245	0	0	_aHPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings. _h[electronic resource]
260			_bPsychoneuroendocrinology _cJun 2008
300			_a654-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aBiomarkers
650	0	4	_aCardiovascular Diseases _xmetabolism
650	0	4	_aDepressive Disorder, Major _xmetabolism
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGlucocorticoids _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aHydrocortisone _xblood
650	0	4	_aHypothalamo-Hypophyseal System _xmetabolism
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPituitary-Adrenal System _xmetabolism
650	0	4	_aPredictive Value of Tests
650	0	4	_aPsychotic Disorders _xmetabolism
650	0	4	_aRegression Analysis
650	0	4	_aSeverity of Illness Index
650	0	4	_aSuicide _xstatistics & numerical data
650	0	4	_aTime Factors
650	0	4	_aUnited States _xepidemiology
700	1		_aFiedorowicz, Jess
700	1		_aZimmerman, Mark
700	1		_aYoung, Elizabeth
773	0		_tPsychoneuroendocrinology _gvol. 33 _gno. 5 _gp. 654-8
856	4	0	_uhttps://doi.org/10.1016/j.psyneuen.2008.02.005 _zAvailable from publisher's website
999			_c17877801 _d17877801